Aurora Cannabis (TSE:ACB) Trading Down 8.7% – Should You Sell?

Aurora Cannabis Inc. (TSE:ACBGet Free Report)’s stock price traded down 8.7% on Thursday . The stock traded as low as C$3.77 and last traded at C$4.19. 1,244,707 shares changed hands during trading, an increase of 205% from the average session volume of 408,107 shares. The stock had previously closed at C$4.59.

Aurora Cannabis Stock Performance

The company has a current ratio of 3.06, a quick ratio of 2.48 and a debt-to-equity ratio of 25.02. The company’s 50-day moving average price is C$4.78 and its two-hundred day moving average price is C$5.32. The company has a market cap of C$248.92 million, a P/E ratio of -2.81 and a beta of 0.17.

Aurora Cannabis (TSE:ACBGet Free Report) last posted its quarterly earnings data on Thursday, June 11th. The company reported C($0.99) earnings per share for the quarter. Aurora Cannabis had a negative net margin of 1.69% and a negative return on equity of 1.15%. The business had revenue of C$38.01 million for the quarter. As a group, equities analysts forecast that Aurora Cannabis Inc. will post -0.22 earnings per share for the current year.

Aurora Cannabis Company Profile

(Get Free Report)

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

Further Reading

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.